ResearchMoz

Global Industrial Robotics Market 2011-2015

Technavio
Published Date » 2012-05-18
No. Of Pages » 35
   
TechNavios analysts forecast the Global Industrial Robotics market to grow at a CAGR of 10.6 percent over the period 20112015. One of the key factors contributing to this market growth is the increasing need to reduce manufacturing costs. The Global Industrial Robotics market has also been witnessing the development of next-generation robotics. However, the continuous decline in unit prices could pose a challenge to the growth of this market.   TechNavios report, the Global Industrial Robotics Market 20112015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Industrial Robotics market landscape and is growth prospects in the coming years. The...
Table Of Contents

1. Executive Summary

2. Introduction

3. Market Coverage

4. Market Landscape

5. Geographical Segmentation

6. Key Leading Countries

7. Vendor Landscape

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Key Vendor Analysis
14.1 ABB Ltd.
14.2 Yaskawa Electric Corp.
14.3 Fanuc Corp.

15. Other Reports in this Series

List of Exhibits:

Exhibit 1: Global Robot Systems Market by Segmentation 2011
Exhibit 2: Global Industrial Robotics Market 20112015 (US$ billion)
Exhibit 3: Global Industrial Robotics Market by Unit Shipments (units in thousands)
Exhibit 4: Global Industrial Robotics Market by End-user Segmentation 2011
Exhibit 5: Global Industrial Robotics Market by Geographical Segmentation 2011
Exhibit 6: Global Industrial Robotics Market by Vendor Segmentation 2011
Exhibit 7: Global Industrial Robotics Market by Average Selling Price 20112015 (US$)

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Orthomyxoviridae Infections Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Orthomyxoviridae infections are caused by a large family of viruses spanning six genera. They are responsible for the occurrence of influenza amongst both humans and animals. Influenzavirus A, Influenzavirus B, Influenzavirus C, Isavirus, Thogotovirus and Quaranjavirus are the six different types of orthomyxoviridae. Each of these genera also include several serotypes or sub-types, Influenza A includes major sub-types such as H1N1, H1N2, H2N2, H3N1, H3N2, H3N8, H5N1, H5N2, H5N3, H5N8, H5N9, H7N1, H7N2, H7N3, H7N4, H7N7, H7N9, H9N2 and H10N7. Thogotovirus includes Batken, Dhori and Jos...
Syngas And Derivatives Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Syngas, also known as synthesis gas, is a mixture of gases consisting primarily of carbon monoxide, hydrogen and often carbon dioxide. Syngas is often used as a fuel for internal combustion engines as this gas is combustible. This gas is used as an intermediate in producing synthetic natural gas (SNG) thus it is called as syngas. Industrially, syngas is used to produce ammonia; methanol and it can be turned in to electricity through gasification process. Syngas plays a vital role in the production of synthetic petroleum as an intermediate which are used as a lubricant or fuel. Comparing...
Paclitaxel Injection Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2013 - 2019
By - Transparency Market Research
Paclitaxel injection is a viscous anticancer drug, derived from the bark of the Pacific yew tree. Paclitaxel belongs to the group of drugs called antineoplastic. Paclitaxel injection is primarily used to treat various advanced stage cancer of the breast,ovaries, Kaposi sarcoma and non-small cell lung cancer. It is type of cytoskeletal medication that targets tubulin, which are a type of globular proteins. The body cells that have defects in chromosome segregation, mitotic spindle assembly and cell division are treated Paclitaxel. Paclitaxel works by inhibiting the growth of cancer cells...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Private Schools Have Higher Male Teaching Staff Than State Schools: Report
Oct 22, 2014  
Private and state education has always been a matter of debate across the UK. A recent study has shown that when it comes to teaching employment options, the difference between state-run and private education in terms of gender balance is absolutely clear.  A report by the Independent Schools Council (ISC) shows that while women dominate both the education medium, the number of...
Abbots First Australian Renewable Energy Deal Rejected
Oct 22, 2014  
The Abbot government’s initial deal for a renewable energy plan has been immediately rejected by the clean energy industry and Labor. The negotiations are about a bipartisan agreement regarding the future of the Australian renewable energy target. The Labor party rejected the first plan as being a job-killer before it was even announced. The plan, they said, would protect solar...
Chemical Production in Europe Flatlines in First Seven Months of 2014
Oct 21, 2014  
The recently published report by European Chemical Industry Council (Cefic) shows overall chemical production in Europe has flatlined in first seven months of this year. Though the initial four months showed a positive trend, the production volumes dropped in July 2014 and in the following months as well. The contraction in output in the three consecutive months has nullified the upward trend...
Actavis to Compete for Omega Pharma
Oct 20, 2014  
Actavic Plc has declared that it will become one of the bidders for the Omega Pharma NV deal, as the United States based drug maker keeps searching for more takeovers. Actavis will be competing against Boehringer Ingelheim GmbH, Sanofi and Perrigi Co. for Omega Pharma. Actavis places themselves as a potential suitor along with quarry in a multitude of potential pharma combinations....
Sale of iPhone Fuels UKs s
Oct 20, 2014  
With the sale of Apple Inc.’s latest smartphone, consumer expenditure on electronics has registered a three-year high this September. The new iPhone 6 and iPhone 6 Plus were launched in the U.K. on September 19 and buyers from across the country raced to purchase the newest smartphone. Both these smartphones are so far the fastest selling Apple products with a sale of over 10 million...